Tofacitinib citrate (CP-690553 citrate)

inquiry

Cat No.

CEI-0193

Description

Tofacitinib citrate (CP-690550) can potently inhibit JAK3 IC50 of 1 nM.

CAS_No

540737-29-9

Molecular Weight

504.49

Purity

>99%

Storage

2 years at -20 centigrade

Targets

JAK3

Molecular Formula

C16H20N6O.C6H8O7

Chemical Name

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate

Solubility

DSMO 101 mg/mL Water

In vitro

Tofacitinib citrate inhibits IL-2-mediated human T cell blast proliferation and IL-15-induced CD69 expression with IC50 of 11 nM and 48 nM. Tofacitinib citrate inhibits interleukin-6-induced phosphorylation of STAT1 and STAT3 with IC50 of 23 nM and 77 nM. Tofacitinib citrate prevents IL-15-induced CD69 expression in human and cynomolgus monkey NK and CD8+ T cells in vitro.

In vivo

Tofacitinib citrate decrease a delayed-type hyper-sensitivity response and extended cardiac allograft survival in murine models. During 2 weeks of Tofacitinib citrate dosing at 10 and 30 mg/kg/d, a significant, time-dependent decrease in NK cell numbers relative to vehicle treatment is observed.

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested

Project Description:

For research and industrial use only, not for personal medicinal use.

Products

Online Inquiry